Dec 23, 2018 · 11m · a16z
Extending Human Lifespan
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
At the a16z Summit, BioAge CEO Kristen Fortney demonstrates how targeting biological aging directly can prevent chronic diseases and significantly extend human healthspan. She details breakthrough longevity discoveries—ranging from genetic mutations and senolytics to young blood factors and AI-driven multi-omics—that are transforming aging research into clinical human therapies.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →
The host as informed peer 0.0 Guest teaching 2.0 Guest disagreement 0.0 The host pushing back 0.0
speaking balance: gold is the host, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 2:10 Critique of NIH Aging Budget
Fortney delivers a mild systemic critique, pointing out that despite aging being the primary driver of major diseases, the NIH allocates only one percent of its budget to basic aging mechanisms.
Hardest push from the host ▶ 0:36 Challenging Disease-Specific MedicineThe presentation challenges standard medical practice by arguing that curing individual diseases like cancer or heart disease sequentially yields minimal overall lifespan extensions.
Biggest teaching moment ▶ 3:00 C. elegans Single-Gene DiscoveryFortney educates the audience on Cynthia Kenyon's groundbreaking 1993 study showing that deleting a single gene could double lifespan, overturning the consensus that aging was too complex to modify simply.
The host holds their own ▶ 9:30 Metformin Retrospective EvidenceThe speaker presents real-world epidemiological proof that diabetic patients on metformin unexpectedly outlived non-diabetics and showed reduced cancer incidence.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The host as informed peer | Guest teaching | Guest disagreement | The host pushing back | Why |
|---|---|---|---|---|---|---|
| Lifespan Impact: Curing Individual Diseases vs. Slowing Aging | 0 | 2 | 0 | 0 | This is a monologue presentation delivered entirely by guest Kristen Fortney with no host interaction present. Fortney explains the medical argument for targeting aging directly rather than individual chronic diseases, contrasting healthspan and lifespan. Host-side scores are zeroed out due to the monologue format. | |
| Breakthrough Discovery: Genetic Modulation in C. elegans | 0 | 2 | 0 | 0 | Fortney provides an educational breakdown of landmark research in longevity, including Cynthia Kenyon's C. elegans single-gene mutation and rapamycin trials in mice and humans. The segment is strictly monologue instruction without host involvement. | |
| Cellular Senescence and Senolytics | 0 | 2 | 0 | 0 | Fortney details cellular senescence, senolytics, and heterochronic parabiosis blood experiments, linking them to BioAge's genomic platform. As a monologue without host participation, host scores remain zero. | |
| Supercentenarian Genetics and Electronic Health Record Mining | 0 | 2 | 0 | 0 | Fortney reviews supercentenarian genetic studies and retrospective EHR analysis for repurposed anti-aging drugs like metformin, closing with naturally long-lived species. Host scores are set to zero for monologue delivery. |
Statements from this episode (17)
Extending lifespan is the most powerful way to address chronic disease
“So I work on extending human lifespans because I believe this is the most powerful way to address chronic disease.”
Age is the primary underlying risk factor for heart disease and cancer
“Now, these are fundamentally very different diseases, different symptoms, different progressions, but they share the same underlying driving risk factor, which is how old you are.”
Curing all cancer would only add four years to average female lifespan
“And scientists have estimated that if we could cure all cancer, that would only get her up to 85. That would add only four years to the average lifespan.”
Biological interventions can reproducibly extend mouse lifespans by up to 30%
“So we can make mice live about 20 to 30% longer.”
Targeting aging directly could extend average human lifespan to 113 years
“That would get the average lifespan up to 113 by targeting aging directly rather than targeting individual diseases one at a time. And what's really key too is this would be an additional 30 years of healthy life.”
Average US healthspan is only 62 before first chronic age-related disease
“The average healthspan is only 62, and that's the age at which you get your first chronic age-related disease.”
Only 1% of the $37B NIH budget funds basic aging research
“So in particular, the NIH, which is sort of all the spending on, on research, on medical research, only about one percent of their thirty seven billion dollar annual budget goes to research on basic mechanisms of aging.”
Cynthia Kenyon doubled C. elegans lifespan via single gene deletion in 1993
“And that sort of idea changed in 1993, ah, when Cynthia Kenyon published this paper about this worm, C. Elegans. So this worm usually only lives two weeks, and she showed that by deleting a single gene in the worm, you could double its lifespan, which was just…”
Rapamycin reproducibly extends middle-aged mouse lifespan by 14% on average
“And this is, I would consider this to be one of the first drugs shown to reproducibly extend mouse lifespan. It's a very solid result. It's been done over and over again, and basically they gave this drug to mice starting from middle age, and it boosted their …”
Phase IIb trial shows rapamycin reduces elderly respiratory infections by 30%
“And they just published their Phase IIb data this summer, showing that Rapamycin can improve certain aspects of immunosenescence. So as you get older, your immune system doesn't work quite so well, and people who took rapamycin had 30% fewer respiratory infect…”
Deleting senescent cells can boost animal lifespan by up to 30%
“If you could delete these cells, that could boost lifespan as much as 30%, ah, and healthspan as well.”
Unity Biotechnology began human Phase 1 trials for osteoarthritis in 2018
“And there's a company working on this as well, Unity Biotechnology, which just started their first phase one study for osteoarthritis earlier this year. So this, one of these drugs went into humans just earlier this year.”
BioAge identified a blood protein linked to longer human lifespan
“One of the targets we're working on now is a protein that circulates in your blood, and we discovered that humans who have higher levels of this protein live longer, are less frail, and are protected from disease.”
Supercentenarian Leila Denmark lived to 114 and practiced medicine until 104
“So this woman here, Leila Denmark, lived until she was a 114 years old, and practiced medicine until she was a 104.”
Retrospective study shows diabetics taking metformin have lower cancer rates
“So metformin is a first-line therapy for diabetes. Millions of people have been taking it for decades, and there was a paper that came out a few years ago where they looked retrospectively and saw that, hey, those diabetics that were taking metformin for decad…”
Current longevity clinical trials could add 10 to 20 healthy years
“Three different therapies are already in the clinic today. So as I mentioned, there are drugs targeting senescence, metformin, and there are drugs targeting rapamycin being tested in clinical trials now. And I think that could already add 10 to 20 years of hea…”
Kristen Fortney argues there is no hard biological limit on lifespan
“Going forward in the future, I think it's a really important point to mention that there is no hard biological limit on how long we can live, and these are a couple really fascinating examples. Bowhead whales, their average lifespan is over 200 years, so they'…”